Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 3/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7413516 | 0.91 | PARP1 (0.41) | ALOX5APCHRNA3GPR119POLBFEN1 | |
| SCHEMBL6583669 | 0.88 | KDM4E (0.40) | ALOX5APCHRNA3GPR119MEN1KMT2A | |
| SCHEMBL7470605 | 0.88 | ALOX5AP (0.41) | ALOX5APCHRNA3GPR119MEN1KMT2A | |
| SCHEMBL7478777 | 0.86 | ALOX5AP (0.39) | ALOX5APCHRNA3GPR119FEN1CHRNB4 | |
| SCHEMBL6584285 | 0.86 | ALOX5AP (0.39) | ALOX5APGPR119FEN1 | |
| SCHEMBL6583119 | 0.86 | ALOX5AP (0.39) | ALOX5APGPR119FEN1 | |
| SCHEMBL6588458 | 0.86 | ALOX5AP (0.39) | ALOX5APGPR119FEN1 | |
| SCHEMBL7134497 | 0.85 | CHRNA3 (0.39) | ALOX5APCHRNA3GPR119FEN1CHRNB4 | |
| SCHEMBL6585098 | 0.84 | RET (0.40) | ALOX5APGPR119FEN1 | |
| SCHEMBL6584732 | 0.84 | ALOX5AP (0.39) | ALOX5APCHRNA3GPR119FEN1CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030087306-A1 | Methods for identifying novel multimeric agents that modulate receptors | THERAVANCE BIOPHARMA R&D IP, LLC | 2003-05-08 | — | — | US | disclosed |
| EP-1082289-A4 | METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS | ADVANCED MEDICINE INC (US) | 2001-03-14 | — | — | EP | disclosed |
| EP-1082289-A1 | METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS | Advanced Medicine, Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999066944-A9 | METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS | ADVANCED MEDICINE INC (US) | 2000-07-27 | — | — | WO | disclosed |
| WO-1999066944-A1 | METHODS FOR IDENTIFYING NOVEL MULTIMERIC AGENTS THAT MODULATE RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-29 | — | — | WO | disclosed |